Abstract:Controlled-release egg albumin-chitosan microspheres containing indomethacin as a model drug were successfully prepared by coacervation method. The proposed method can offer a simple method for microsphere preparation in an aqueous system with the elimination of the use of organic solvents that are usually needed in conventional techniques of microencapsulation. The interaction between negatively charged egg albumin molecules in phosphate buffer, pH 7.2, or sodium hydroxide solution and positively charged chitosan molecules dissolved in diluted acetic acid to form an insoluble precipitate was the principle for the formation of the microspheres. The effects of many process variables, such as amount of formaldehyde as a cross-linking agent, stirring time, final pH of encapsulation medium, initial drug loading, and albumin concentration or albumin-to-chitosan weight ratio, on the properties of the prepared microspheres were investigated. Incorporation efficiencies of the microspheres to the drug were high in most cases and ranged between 63.3 +/- 3.6% and 92.39 +/- 3.2%, while particle sizes were 435.2 +/- 12.6 up to 693.9 +/- 34.6 microm for the different tested batches. On the other hand, the values of angles of repose and compressibility indices were in the range of 23.5 +/- 0.4 to 32.0 +/- 0.7 degrees and 11.1 +/- 0.7% to 23.6 +/- 0.7% respectively, which indicate overall good free flowing nature of the microspheres of all batches. The maximum required amount of the cross-linking agent was determined to avoid excessive unnecessary chemicals. It was also noticed that excessive time of stirring and excessive initial drug loading are not recommended as it may lead to microspheres of low properties. The pH of the encapsulation media (pH 3.77 up to pH 4.91) significantly affected the properties of the microspheres. As the pH of the encapsulation media was increased, the incorporation efficiency, particle size, and flowability decreased, along with increase of drug release rate, which could be related to incomplete cross linking of the microspheres matrix. It was also observed that high concentration of albumin solution and accordingly the increase of albumin-to-chitosan weight ratio were accompanied with increases in incorporation efficiency and particle size with improved microsphere flowability and slow indomethacin release. Thus, the proposed microspheres showed the ability to control the release of indomethacin, and their properties were highly affected by many process variables that could be controlled to obtain an optimized system.

Optimized preparation of daidzein-loaded chitosan microspheres and in vivo evaluation after intramuscular injection in rats.

Enhanced Oral Bioavailability of Daidzein by Self-Microemulsifying Drug Delivery System

Preparation, drug releasing property and pharmacodynamics of soy isoflavone-loaded chitosan microspheres

[Preparation and in vitro property evaluation of β-cyclodextrin-daidzein/PEG_(20000)/Carbomer_(940) nanocrystals]

The Comparison of Different Daidzein-Plga Nanoparticles in Increasing Its Oral Bioavailability

Optimization and bioavailability evaluation of self-microemulsifying drug delivery system of the daidzein–nicotinamide complex

Preparation of Daidzein microparticles through liquid antisolvent precipitation under ultrasonication

Synthesis, Characterization, and Evaluation of Genistein-Loaded Zein/Carboxymethyl Chitosan Nanoparticles with Improved Water Dispersibility, Enhanced Antioxidant Activity, and Controlled Release Property

Analysis of Daidzein in Nanoparticles after Oral Co-Administration with Sodium Caprate to Rats by Ultra-Performance Liquid Chromatography–quadrupole-Time-of-flight Mass Spectrometry

Preparation of inclusion complex of daidzein and hydropropyl-β- cyclodextrin

Mucin Coated Protein-Polyphenol Microcarriers for Daidzein Delivery

Application of Central Composite Design-Based Response Surface Methodology in Optimization of the Preparation Process of Sanguinarine Chitosan Microspheres

Preparation and Characterization of Electrosprayed Daidzein–loaded PHBV Microspheres

Preparation and in vitro compatibility of transforming growth factor beta 1 loaded chitosan microspheres

Design, synthesis and the evaluation of cholinesterase inhibition and blood‐brain permeability of daidzein derivatives or analogs

[Pharmacokinetics, pharmacodynamics, and tissue distribution of oral co-loaded puerarin/daidzein mixed micelles in rats]

Preparation, characterization, stability, and controlled release of chitosan-coated zein/shellac nanoparticles for the delivery of quercetin

Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin

Preparation and evaluation of chitosan–hydrophobic silica composite microspheres: Role of hydrophobic silica in modifying their properties

Bioprocess of Uniform-Sized Crosslinked Chitosan Microspheres in Rats Following Oral Administration.

[Optimization of preparation technology for Acanthopanax senticosus total saponins microemulsion by D-optimal mixture design and intestinal absorption characteristics].